| Dr Harry Karl Tweel, MD | |
|
703 7th Ave, Huntington, WV 25701-2115 | |
| (304) 523-6483 | |
| (304) 523-6482 |
| Full Name | Dr Harry Karl Tweel |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 703 7th Ave, Huntington, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275879868 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 9293 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harry Karl Tweel, MD 703 7th Ave, Huntington, WV 25701-2115 Ph: (304) 523-6483 | Dr Harry Karl Tweel, MD 703 7th Ave, Huntington, WV 25701-2115 Ph: (304) 523-6483 |
News Archive
Pregnant women and new mothers receive many messages regarding the benefits of exclusive breastfeeding for babies in the first year of life. Breastfeeding is thought to reduce the risk of allergic rhinitis (hay fever), asthma, food allergies and eczema in children.
A new study has found that an alternative way of screening for pre-eclampsia in pregnant women may be more accurate than the current recommended method.
Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.
Tibotec Pharmaceuticals today announced that it has entered into a license agreement with Gilead Sciences, Inc., for the development and commercialization of a new once-daily single tablet fixed-dose antiretroviral combination product containing Tibotec's protease inhibitor PREZISTA® (darunavir) and Gilead's cobicistat, an investigational pharmacoenhancing or "boosting" agent.
› Verified 5 days ago
Leonard White, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1249 15th St, Suite 2000, Huntington, WV 25701 Phone: 304-691-1000 Fax: 304-691-1153 | |
George J Linsenmeyer Iii, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1249 15th St Ste 4000, Huntington, WV 25701 Phone: 304-691-8500 | |
Maria Gracia Luzuriaga Bassante, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1249 15th St Ste 3000, Huntington, WV 25701 Phone: 304-691-1000 | |
Dr. Everett B Wray Iii, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1249 15th Street, Suite 4000, Huntington, WV 25701 Phone: 304-691-8500 Fax: 304-691-8510 | |
Mustafa Awili, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2900 First Avenue, Room 1025, Huntington, WV 25702 Phone: 304-399-7484 Fax: 304-399-7579 | |
Helgi K Sigmundsson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5170 Us Rt 60 East, Huntington, WV 25705 Phone: 304-528-4600 | |
Sara Catherine Allman, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1540 Spring Valley Dr, Huntington, WV 25704 Phone: 304-429-6741 Fax: 304-429-0362 |